DDAH1 and pulmonary arterial hypertension: Dimethylarginine dimethylaminohydrolase 1 (DDAH1) knockout rats showed significantly increased plasma and pulmonary ADMA content and decreased eNOS protein content and NO release, aggravating oxidative stress, pulmonary vascular remodeling, and fibrosis in MCT-induced PAH rats.